The present study uncovered a rare co-occurrence of KRAS (G13D) and BRAF (V600E) alterations in CRC, highlighting tumor heterogeneity and challenging the assumption that these mutations are mutually exclusive within the studied ethnicity. This evidence concerns the gene KRAS and colorectal carcinoma.